Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

China flag China · Delayed Price · Currency is CNY
3.680
-0.010 (-0.27%)
Apr 29, 2026, 3:00 PM CST
0.00%
Market Cap 9.27B
Revenue (ttm) 15.96B
Net Income (ttm) 309.80M
Shares Out 2.52B
EPS (ttm) 0.12
PE Ratio 30.75
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 96,110,898
Average Volume 218,321,378
Open 3.650
Previous Close 3.690
Day's Range 3.580 - 3.690
52-Week Range 3.200 - 4.880
Beta 0.19
RSI 45.91
Earnings Date Apr 23, 2026

About SHA:600664

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, Chinese medicines, and antibiotics. It also provides calcium ... [Read more]

Sector Healthcare
Founded 1991
Employees 10,180
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600664
Full Company Profile

Financial Performance

In 2025, SHA:600664's revenue was 15.96 billion, a decrease of -1.31% compared to the previous year's 16.18 billion. Earnings were 361.60 million, a decrease of -42.50%.

Financial Statements

News

There is no news available yet.